CTOs on the Move

St. Mary Medical Center Foundation

www.stmaryfoundation.org

 
St. Mary Medical Center Foundation is a Langhorne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Innovative Health Strategies

Innovative Health Strategies, Inc. is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alliance Home Health Care

Alliance Home Health Care and Adult Day Services is a company of integrity which prides itself on treating our clients and employees as family. It is our mission to insure that all our clients get the best possible care either through our services or by

Jack Hughston Memorial

Hughston Clinic Pc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Auburn, AL. To find more information about Hughston Clinic Pc, please visit www.hughston.com

Perfect Health

Perfect Health, an independent privately held company based in Cambridge, MA, is a full service primary care practice that sees seniors in their own homes.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.